Thus, the perturbation of IGF-1 signaling, as with the use of IGF-1/R inhibitors, may negatively impact the function or survival of mature SGNs, leading to the onset of otologic AEs such as hearing loss or tinnitus. This evidence concerns the gene IGF1 and Tinnitus.